1,114
edits
Changes
DMI Sodium Butyrate and Saccharin CTA Controls 2 (view source)
Revision as of 11:07, 5 July 2022
, 11:07, 5 July 2022added infobox
Line 1:
Line 1:
[[Category:Flavor Preference]]
Replication (to increase N) of [[DMF Sodium Butyrate and Saccharin-LiCl CTA]] and [[DMG Sodium Butyrate and Saccharin-LiCl CTA]] and [[DMH Sodium Butyrate and Saccharin CTA Controls]] with NaCl-conditioned control groups.
Replication (to increase N) of [[DMF Sodium Butyrate and Saccharin-LiCl CTA]] and [[DMG Sodium Butyrate and Saccharin-LiCl CTA]] and [[DMH Sodium Butyrate and Saccharin CTA Controls]] with NaCl-conditioned control groups.
+
+{{Infobox experiment|align=right
+| Name = Butyrate and Lithium-CTA pt3
+| project = Histone Acetylation
+| code = DMI
+| protocol = 1917
+| funding = Chair's Fund
+| investigators = Mukherjee, Houpt
+| species = rat
+| date = 2021-2-9
+| type = CTA
+| drugs = butyrate, lithium
+| data = https://houptlab.org/bartab/expt/?id=DMI
+}}
+
+
+
Test if systemic Sodium Butyrate (NaB), an HDAC inhibitor, enhances CTA learning .
Test if systemic Sodium Butyrate (NaB), an HDAC inhibitor, enhances CTA learning .
Line 68:
Line 85:
−[[Category:Taste Aversion]]
[[Category:Taste Aversion]]
+[[Category:CTA Experiments]]
+[[Category:Epigenetics]]